Genomic copy number alterations in non-syndromic hearing loss

Area of Science:

• Genetics
• Genomics
• Audiology

Background:

• Genetic heterogeneity presents challenges in identifying genes linked to hearing impairment.
• Recurrence risk estimates for hearing loss can be imprecise without clear phenotypic etiology, often relying on family segregation data.

Purpose of the Study:

• To investigate the role of rare copy number variants (CNVs) in non-syndromic hearing loss.
• To assess the impact of identified CNVs on genetic counseling and inheritance pattern determination.

Main Methods:

• Oligonucleotide array-comparative genomic hybridization (array-CGH) was used to profile patients with non-syndromic hearing loss.
• Segregation analysis within pedigrees was performed to validate the causative role of detected CNVs.

Main Results:

• Rare CNVs were detected in 12 probands, with four CNVs involving known hearing loss genes (POU4F3, EYA4, USH2A, BCAP31).
• Genomic imbalance was confirmed as a contributor to non-syndromic deafness.
• Segregation analysis excluded CNVs in six cases, and a point mutation was implicated in another, indicating incorrect presumptive inheritance patterns in at least two instances.
• The first duplication reciprocal to a known deletion syndrome was reported, causing only hearing impairment.

Conclusions:

• Genomic imbalance plays a significant role in non-syndromic hearing loss.
• The study highlights the importance of CNV analysis for accurate genetic diagnosis and counseling in hearing impairment.
• Presumptive inheritance patterns may be inaccurate, necessitating molecular testing for precise genetic assessment.